J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg

Short descriptor: Inj cefazolin sodium, hikma

✓ Active HCPCS Level II 2026
Open J0688 in the app →

Look up J0688 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

J0688 is the HCPCS Level II code for Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2025-01-01
2026 Maintenance
No change this year

Drug Details

Drug / Substance
cefazolin sodium, not therapeutically equivalent to j0690
Dose / Unit
500 mg
Route
Injection

See the full HCPCS Table of Drugs (J-codes).

References

Cite This Page

Reference J0688 with the canonical source and edition:

J0688 — Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J0688

Canonical URL: https://icd10codingpro.com/hcpcs-codes/J0688

Related Codes in Section J

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial